Explainer
Infectious disease in 2026: a crash course
WHO estimates around a billion cases of seasonal flu a year, causing 290,000 to 650,000 respiratory deaths, and about one in six lab-confirmed bacterial infections in 2023 resisted antibiotic treatment.[1][2] Canada lost its measles elimination status in November 2025, and the CDC had counted 5,412 US measles cases in 2026 as of 12 November, up from 2,289 in all of 2025.[3][4][5]
Infectious diseases range from the flu that circulates every winter to rare bacterial infections that make headlines. This crash course starts with how outbreaks are tracked and vaccine advice is set, then covers respiratory viruses, measles and meningitis, plague and antimicrobial resistance, pointing to ContentLora’s explainers, trackers and debates along the way. Seasonal flu alone causes an estimated 290,000 to 650,000 respiratory deaths a year, according to WHO.[1]
This page is general information, not medical advice. If you are unwell or worried about an infection or a vaccine, talk to a doctor, pharmacist or your local health department, and follow your national health agency’s guidance. In an emergency, call your local emergency number.
How outbreaks are tracked and vaccine advice is set
In the US, the CDC receives case data on serious diseases from state, local and territorial health departments through its National Notifiable Diseases Surveillance System.[6] It sets the adult and childhood vaccine schedules based on recommendations from its Advisory Committee on Immunization Practices (ACIP).[7]
That system changed in 2026. On 5 January 2026 HHS cut the number of diseases covered by universally recommended childhood vaccines from 17 to 11.[8] On 16 March a federal court stayed the appointments and votes of the reconstituted ACIP and blocked the new schedule, returning the childhood schedule to its earlier form.[9][10] As of 7 November 2026, CDC listed all of ACIP’s 2026 meetings as cancelled because of the litigation.[11] Internationally, the United States formally left the WHO on 22 January 2026, according to HHS.[12]
Flu and RSV
Seasonal flu is an acute respiratory infection that most people recover from without treatment, but pregnant women, children under 5, older people and people with chronic conditions face greater risk of severe illness.[13][14] Flu vaccines are updated regularly because the viruses keep evolving, and all three components of the 2026-27 northern hemisphere recommendation differ from the previous season’s vaccine.[15][16] In August 2026 the FDA approved the first mRNA-based flu vaccine, for adults 50 and older.[17] In the week ending 7 November 2026, the CDC said US flu activity was still increasing in many parts of the country and higher than usual for the time of year.[18] Start with seasonal flu explained, then how flu vaccine strains are chosen and the 2026-27 flu season tracker.
Respiratory syncytial virus (RSV) is one of the most common causes of lower respiratory infections in children and also causes severe disease in older people.[19] Infants under 6 months face the highest risk.[20] Since 2023 the FDA has approved vaccines for older adults, a vaccine given in pregnancy to protect newborns, and antibody products for infants.[21][22][23][24] See RSV explained.
Measles and meningitis
Measles is a highly contagious airborne virus, and up to 9 in 10 unprotected close contacts of an infected person catch it.[25][26] Two doses of MMR vaccine are 97% effective, according to the CDC.[27] The CDC counted 2,289 US cases in 2025 and 5,412 in 2026 as of 12 November.[5][4] Canada lost its elimination status in November 2025, and PAHO’s verification commission set out to review the status of the United States and Mexico.[3][28] See measles explained.
Meningitis is an infection of the layers around the brain and spinal cord, and WHO says about 1 in 6 people who get bacterial meningitis die.[29][30] The US reported 463 meningococcal cases in 2025 (preliminary), the second-highest count since 2013, and a MenB outbreak in Kent, England, killed two people in March 2026.[31][32] The UK responded with a one-off MenB vaccine programme for older teenagers and new students.[33] Read meningitis explained, the meningitis vaccines guide, the vaccine policy debate and the meningitis outbreaks tracker. The neisseria-meningitidis page covers the bacterium itself.
Plague
Plague is caused by the bacterium Yersinia pestis, usually found in small mammals and their fleas.[34] It still occurs: ten countries reported nearly 4,000 human cases and 423 deaths to WHO between 2019 and 2025.[35] Common antibiotics cure it if given early.[36] In October 2026 a suspected plague death in Irkutsk, Russia drew attention, but Russian regulators told WHO there was no plague case, and contact monitoring ended with no dangerous pathogens found.[37][38] See plague explained and how worried people should be about Russia’s plague scare.
Antimicrobial resistance
Antimicrobial resistance (AMR) happens when bacteria, viruses, fungi and parasites stop responding to medicines, making infections hard or impossible to treat.[39] A 2024 Lancet study estimated that bacterial AMR directly caused 1.14 million deaths in 2021.[40] Misuse and overuse of antibiotics is one of the main drivers.[41] WHO counted 90 antibacterials in clinical development in 2025, down from 97 in 2023, and only 15 of them were innovative.[42][43] In May 2026 the World Health Assembly adopted an updated global action plan for 2026 to 2036, and a ministerial conference in Abuja is scheduled for 6 to 8 December 2026.[44][45] See antibiotic resistance explained, how new antibiotics are developed and the AMR tracker.
Suggested order: the CDC page first for how surveillance and vaccine advice work, then each disease’s explainer, guide, tracker and debate in turn. The antimicrobial resistance pages come last because resistance affects how every bacterial infection above is treated. The general health crash course covers how vaccines and drugs are tested and approved.
Read next
Neisseria meningitidis (meningococcus)
Neisseria meningitidis causes meningococcal meningitis and sepsis. Its serogroups, who is at risk, US and UK trends in 2025-2026, and vaccines.
Questions readers ask
Why do flu vaccines change every year?
Flu viruses evolve continuously, so the vaccines must be reviewed and updated regularly. WHO usually makes its recommendation in February for the northern hemisphere and September for the southern hemisphere, leaving about 6 to 8 months for production and approval.[15][46]
How contagious is measles?
Up to 9 in 10 unprotected close contacts of a person with measles become infected, and the virus can stay contagious in the air or on surfaces for up to two hours. The CDC says two doses of MMR vaccine are 97% effective against measles.[26][27]
Is there one vaccine that prevents all meningitis?
No. Licensed vaccines target the most harmful meningococcal, pneumococcal and Haemophilus influenzae strains, but no universal meningitis vaccine exists.[47]
Can plague be treated?
Yes, if treated early. Common antibiotics can cure plague, and WHO says recovery rates are high when treatment starts within 24 hours of symptoms. Untreated pneumonic plague can be fatal within 18 to 24 hours.[36]
What drives antibiotic resistance?
WHO says misuse and overuse of antibiotics, such as taking them when they are not needed or taking the wrong type, remains one of the main drivers.[41]
Sources
· 47 claims from 23 publishers
Each numbered claim is a statement we checked against the sources listed with it. Tap a number in the text to see its sources in place.
- [1]
WHO estimates around a billion cases of seasonal influenza a year, causing 290,000 to 650,000 respiratory deaths annually. confirmedas of 2026-11-07
- Influenza (seasonal) fact sheet · World Health Organization · Primary source · 2025-02-28 · Key facts (retrieved 2026-11-07)
- Influenza (seasonal) fact sheet · World Health Organization · Primary source · 2025-02-28 · Key facts (retrieved 2026-11-07)
- [2]
About one in six laboratory-confirmed bacterial infections worldwide in 2023 were resistant to antibiotic treatment, according to WHO's Global antibiotic resistance surveillance report 2025. confirmedas of 2025-10-13
- WHO warns of widespread resistance to common antibiotics worldwide · World Health Organization · Primary source · 2025-10-13 (retrieved 2026-11-07)
- Antimicrobial resistance (fact sheet) · World Health Organization · Primary source · 2026-07-16 (retrieved 2026-11-07)
- [3]
Canada first achieved measles elimination in 1998 and lost the status on 10 November 2025, after a national outbreak that began in October 2024. confirmedas of 2026-11-07
- Measles: Canada's response · Public Health Agency of Canada · Primary source · 2026-04-14 (retrieved 2026-11-07)
- Measles: For health professionals · Public Health Agency of Canada · Primary source (retrieved 2026-11-07)
- [4]
As of 12 November 2026 the CDC had counted 5,412 confirmed US measles cases in 2026, with 43 new outbreaks and 96% of cases outbreak-associated. confirmedas of 2026-11-12
- Measles Cases and Outbreaks (update of 12 November 2026) · US Centers for Disease Control and Prevention · Primary source (retrieved 2026-11-14)
- Measles Cases and Outbreaks (update of 12 November 2026) · US Centers for Disease Control and Prevention · Primary source (retrieved 2026-11-14)
- [5]
The CDC counted 2,289 confirmed US measles cases in 2025 across 48 outbreaks, with 90% of cases outbreak-associated. confirmedas of 2026-11-05
- Measles Cases and Outbreaks · US Centers for Disease Control and Prevention · Primary source (retrieved 2026-11-07)
- Measles Cases and Outbreaks · US Centers for Disease Control and Prevention · Primary source (retrieved 2026-11-07)
- [6]
CDC's National Notifiable Diseases Surveillance System (NNDSS) receives and shares case data from state, local and territorial health departments to help monitor, control and prevent serious diseases. confirmedas of 2026-01-14
- About NNDSS · Centers for Disease Control and Prevention · Primary source · 2026-01-14 · Read through WebFetch (cdc.gov blocks curl); page updated 14 January 2026 (retrieved 2026-11-07)
- [7]
The Advisory Committee on Immunization Practices (ACIP) is a federal advisory committee of medical and public health experts that develops recommendations on vaccine use, and CDC sets the US adult and childhood immunisation schedules based on its recommendations. confirmedas of 2025-08-12
- About ACIP · Centers for Disease Control and Prevention · Primary source · 2025-08-12 · Read through WebFetch (cdc.gov blocks curl) (retrieved 2026-11-07)
- About ACIP · Centers for Disease Control and Prevention · Primary source · 2025-08-12 · Read through WebFetch (cdc.gov blocks curl) (retrieved 2026-11-07)
- [8]
On 5 January 2026 HHS cut the number of diseases covered by universally recommended childhood vaccines from 17 to 11, moving MenACWY and MenB to high-risk groups and placing meningococcal vaccination under shared clinical decision-making for others. confirmedas of 2026-01-09
- HHS announces unprecedented overhaul of US childhood vaccine schedule · CIDRAP (University of Minnesota) · Secondary source · 2026-01-05 · Subheading (retrieved 2026-10-11)
- HHS announces unprecedented overhaul of US childhood vaccine schedule · CIDRAP (University of Minnesota) · Secondary source · 2026-01-05 (retrieved 2026-10-11)
- The CDC Just Sidelined These Childhood Vaccines. Here's What They Prevent · NPR · Secondary source · 2026-01-09 (retrieved 2026-10-11)
- [9]
On 16 March 2026 a federal district court in Massachusetts, in American Academy of Pediatrics v. Kennedy, stayed the 13 ACIP appointments and all votes of the reconstituted committee since June 2025. confirmedas of 2026-03-17
- Brief for Federal Defendants-Appellants, AAP v. Kennedy, No. 26-1503 (1st Cir.) · US Department of Justice (court filing, hosted by Courthouse News) · Primary source · 2026-06-18 · Statement of the case, pp. 11-12 ("On March 16, 2026, the district court granted the preliminary injunction motion in part."); cover: "United States District Court for the District of Massachusetts" (retrieved 2026-10-10)
- The State of US Vaccine Policy: Special Edition - Mar 17, 2026 · CIDRAP (University of Minnesota) · Secondary source · 2026-03-17 (retrieved 2026-10-10)
- Judge Pauses Pediatricians' Lawsuit Over Kennedy's Vaccine Changes as Families Await October 6 Appeals Court Argument · Medical Daily · Secondary source · 2026-09-15 (retrieved 2026-10-10)
- [10]
The 16 March 2026 court stay blocked the January 2026 schedule memo and returned the childhood schedule to its earlier form; CDC's meningococcal guidance, reviewed on 30 March 2026, again lists routine MenACWY at ages 11-12. confirmedas of 2026-10-11
- The State of US Vaccine Policy: Special Edition - Mar 17, 2026 · CIDRAP (University of Minnesota) · Secondary source · 2026-03-17 (retrieved 2026-10-10)
- Meningococcal Vaccine Recommendations · US Centers for Disease Control and Prevention · Primary source · 2026-03-30 · page last reviewed 30 March 2026 (retrieved 2026-10-11)
- [11]
As of 7 November 2026, CDC listed ACIP's last meeting as 4-5 December 2025 and its March, June and October 2026 meetings as cancelled due to ongoing litigation, with meetings scheduled for 2027. confirmedas of 2026-11-07
- ACIP Meetings · Centers for Disease Control and Prevention · Primary source · 2026-10-09 · Read through WebFetch (cdc.gov blocks curl) on 2026-11-07 about 15:15 UTC; page updated 9 October 2026 (retrieved 2026-11-07)
- ACIP Meetings · Centers for Disease Control and Prevention · Primary source · 2026-10-09 · Re-checked by reviewer through WebFetch on 2026-11-07; 2025 list ends "December 4-5, 2025"; 2027 list starts "February 24-26" (retrieved 2026-11-07)
- ACIP Meetings · Centers for Disease Control and Prevention · Primary source · 2026-10-09 · Re-checked by reviewer through WebFetch on 2026-11-07 (retrieved 2026-11-07)
- [12]
According to HHS, the United States formally exited WHO on 22 January 2026 after the one-year notice period, terminated all US government funding to WHO, and ceased official participation in WHO committees, governance bodies and technical working groups. confirmedas of 2026-02-23
- HHS Fact Sheet: U.S. Withdrawal from the World Health Organization · US Department of Health and Human Services (on cdc.gov) · Primary source · 2026-02-23 · Also read via WebFetch (retrieved 2026-11-07)
- HHS Fact Sheet: U.S. Withdrawal from the World Health Organization · US Department of Health and Human Services (on cdc.gov) · Primary source · 2026-02-23 (retrieved 2026-11-07)
- HHS Fact Sheet: U.S. Withdrawal from the World Health Organization · US Department of Health and Human Services (on cdc.gov) · Primary source · 2026-02-23 (retrieved 2026-11-07)
- [13]
Seasonal influenza is an acute respiratory infection caused by influenza viruses, common in all parts of the world, and most people recover without treatment. confirmedas of 2026-11-07
- Influenza (seasonal) fact sheet · World Health Organization · Primary source · 2025-02-28 · Overview (retrieved 2026-11-07)
- [14]
WHO says people at greater risk of severe flu are pregnant women, children under 5, older people, people with chronic medical conditions and people with immunosuppressive conditions or treatments. confirmedas of 2026-11-07
- Influenza (seasonal) fact sheet · World Health Organization · Primary source · 2025-02-28 · Epidemiology (retrieved 2026-11-07)
- Influenza (seasonal) fact sheet · World Health Organization · Primary source · 2025-02-28 · Signs and symptoms (retrieved 2026-11-07)
- [15]
Unlike many vaccines, seasonal flu vaccines must be evaluated and updated regularly because circulating influenza viruses evolve continuously. confirmedas of 2026-02-27
- Questions and answers: recommended composition of influenza virus vaccines for the northern hemisphere 2026-2027 season · World Health Organization · Primary source · 2026-02-27 · Question 1 (retrieved 2026-11-07)
- [16]
All three components of the 2026-27 northern hemisphere recommendation differ from the 2025-26 northern hemisphere vaccine, and the H3N2 and B components also differ from the 2026 southern hemisphere vaccine. confirmedas of 2026-02-27
- Questions and answers: recommended composition of influenza virus vaccines for the northern hemisphere 2026-2027 season · World Health Organization · Primary source · 2026-02-27 · Question 6 (retrieved 2026-11-07)
- Questions and answers: recommended composition of influenza virus vaccines for the northern hemisphere 2026-2027 season · World Health Organization · Primary source · 2026-02-27 · Q (PDF) (retrieved 2026-11-07)
- [17]
In August 2026 the FDA approved Moderna's mFLUSIVA (mRNA-1010) for adults 50 and older, the first mRNA-based influenza vaccine and Moderna's fourth FDA-approved product after Spikevax, mRESVIA and mNEXSPIKE. confirmedas of 2026-08-06
- Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA · Moderna (press release) · Primary source · 2026-08-06 (retrieved 2026-10-10)
- FDA Approves Moderna's mRNA Flu Vaccine After Phase 3 Success · AJMC · Secondary source · 2026-08-06 (retrieved 2026-10-10)
- [18]
In the week ending 7 November 2026, the CDC said US seasonal flu activity was still increasing in many parts of the country and was higher than usual for that time of year. confirmedas of 2026-11-13
- Weekly US Influenza Surveillance Report (FluView): key updates for week 44, ending November 7, 2026 · US Centers for Disease Control and Prevention · Primary source · 2026-11-13 · Key points (retrieved 2026-11-14)
- [19]
WHO describes respiratory syncytial virus (RSV) as one of the most common causes of acute lower respiratory infections in children worldwide, and a cause of substantial severe respiratory disease in older people. confirmedas of 2026-11-07
- Respiratory syncytial virus (RSV) fact sheet · World Health Organization · Primary source · Key facts (retrieved 2026-11-07)
- [20]
WHO says infants, especially those under 6 months, are at the highest risk of severe RSV disease and death, and about half of child RSV deaths occur in infants under 6 months. confirmedas of 2026-11-07
- Respiratory syncytial virus (RSV) fact sheet · World Health Organization · Primary source · Overview (retrieved 2026-11-07)
- Respiratory syncytial virus (RSV) fact sheet · World Health Organization · Primary source · Scope of the problem (retrieved 2026-11-07)
- [21]
On 3 May 2023 the FDA approved GSK's Arexvy, the first RSV vaccine approved in the US, for adults 60 and older. confirmedas of 2023-05-03
- FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine · US Food and Drug Administration · Primary source · 2023-05-03 (retrieved 2026-11-07)
- [22]
On 21 August 2023 the FDA approved Pfizer's Abrysvo as the first vaccine for use in pregnancy to protect infants from RSV lower respiratory tract disease from birth to 6 months; the label specifies 32 through 36 weeks of pregnancy, and Abrysvo had been approved in May 2023 for adults 60 and older. confirmedas of 2023-08-21
- FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV in Infants · US Food and Drug Administration · Primary source · 2023-08-21 (retrieved 2026-11-07)
- FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV in Infants · US Food and Drug Administration · Primary source · 2023-08-21 (retrieved 2026-11-07)
- [23]
On 17 July 2023 the FDA approved Beyfortus (nirsevimab) to prevent RSV lower respiratory tract disease in newborns and infants in their first RSV season, and in children up to 24 months who remain vulnerable through their second season. confirmedas of 2023-07-17
- FDA Approves New Drug to Prevent RSV in Babies and Toddlers · US Food and Drug Administration · Primary source · 2023-07-17 (retrieved 2026-11-07)
- [24]
On 9 June 2025 the FDA approved Merck's Enflonsia (clesrovimab) to prevent RSV lower respiratory tract disease in newborns and infants born during or entering their first RSV season. confirmedas of 2025-06-09
- U.S. FDA Approves Merck's ENFLONSIA (clesrovimab-cfor) for Prevention of RSV Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season · Merck (press release) · Primary source · 2025-06-09 (retrieved 2026-11-07)
- Merck's Clesrovimab (Enflonsia) Receives FDA Approval to Protect Infants From RSV During First Season · Contagion Live · Secondary source · 2025-06-09 (retrieved 2026-11-07)
- [25]
WHO describes measles as a highly contagious, serious airborne disease caused by a virus that can lead to severe complications and death. confirmedas of 2026-11-07
- Measles - fact sheet · World Health Organization · Primary source · Key facts (retrieved 2026-11-07)
- [26]
Up to 9 in 10 unprotected close contacts of a person with measles become infected, and the virus can stay active and contagious in the air or on surfaces for up to two hours. confirmedas of 2026-11-07
- About Measles · US Centers for Disease Control and Prevention · Primary source (retrieved 2026-11-07)
- Measles - fact sheet · World Health Organization · Primary source · Transmission (retrieved 2026-11-07)
- [27]
The CDC says one dose of MMR vaccine is 93% effective against measles and two doses are 97% effective. confirmedas of 2026-11-07
- Measles Vaccination · US Centers for Disease Control and Prevention · Primary source (retrieved 2026-11-07)
- Measles Vaccination · US Centers for Disease Control and Prevention · Primary source (retrieved 2026-11-07)
- [28]
After the 2025 outbreaks, PAHO's verification commission set out to review whether the United States and Mexico keep their measles elimination status. confirmedas of 2026-11-07
- Meeting to determine US measles elimination status pushed back to November (CNN, via ABC17 News) · CNN · Secondary source · 2026-03-02 (retrieved 2026-11-07)
- Understanding Current U.S. Measles Outbreaks and Elimination Status · Association of State and Territorial Health Officials · Secondary source · 2026-01-21 (retrieved 2026-11-07)
- [29]
Meningitis is an infection of the protective layers covering the brain and spinal cord, and it can be life-threatening if not treated quickly. confirmedas of 2026-10-11
- Meningitis · NHS (UK) · Primary source (retrieved 2026-10-11)
- [30]
WHO says about 1 in 6 people who get bacterial meningitis die and 1 in 5 have severe complications. confirmedas of 2026-10-11
- Meningitis (fact sheet) · World Health Organization · Primary source (retrieved 2026-10-11)
- [31]
The US reported 463 confirmed and probable meningococcal cases in 2025 (preliminary), the second-highest count since 2013; cases have risen sharply since 2021, driven largely by serogroup Y, and generally peak each year in January to March. confirmedas of 2026-09-29
- Meningococcal Disease Surveillance and Trends · US Centers for Disease Control and Prevention · Primary source (retrieved 2026-10-11)
- Meningococcal Disease Surveillance and Trends · US Centers for Disease Control and Prevention · Primary source (retrieved 2026-10-11)
- Meningococcal Disease Surveillance and Trends · US Centers for Disease Control and Prevention · Primary source (retrieved 2026-10-11)
- [32]
A meningococcal disease outbreak in Kent, England, in March 2026 was linked to a MenB strain, and two people died. confirmedas of 2026-03-18
- Kent meningitis outbreak: March 2026 · UK Health Security Agency (blog) · Primary source · 2026-03-18 (retrieved 2026-10-11)
- Kent meningitis outbreak: March 2026 · UK Health Security Agency (blog) · Primary source · 2026-03-18 (retrieved 2026-10-11)
- [33]
The UK introduced a one-off, time-limited MenB vaccine programme in response to the 2026 outbreaks while JCVI reviews the evidence, offering two doses to 17- and 18-year-olds born 1 September 2007-31 August 2008 and to under-25s starting university or residential further education for the first time in autumn 2026. confirmedas of 2026-06-12
- Who is eligible for the 2026 one-off MenB vaccine programme? · UK Health Security Agency (blog) · Primary source · 2026-06-12 (retrieved 2026-10-11)
- Who is eligible for the 2026 one-off MenB vaccine programme? · UK Health Security Agency (blog) · Primary source · 2026-06-12 (retrieved 2026-10-11)
- Meningitis · NHS (UK) · Primary source (retrieved 2026-10-11)
- [34]
Plague is caused by the bacterium Yersinia pestis, which is usually found in small mammals and their fleas. confirmedas of 2026-10-11
- Plague (fact sheet) · World Health Organization · Primary source (retrieved 2026-10-11)
- About Plague · US Centers for Disease Control and Prevention · Primary source · 2026-08-24 (retrieved 2026-10-11)
- [35]
Ten countries reported nearly 4,000 human plague cases and 423 deaths to WHO between 2019 and 2025. confirmedas of 2026-10-07
- 'No plague case' in Siberia, Russia tells WHO as assessments continue · UN News · Primary source · 2026-10-07 (retrieved 2026-10-11)
- Pneumonic plague, by the numbers · CNN · Secondary source · 2026-10-08 (retrieved 2026-10-11)
- [36]
Untreated pneumonic plague can be fatal within 18 to 24 hours of onset, but common antibiotics can cure it if given early; WHO says recovery rates are high when treatment starts within 24 hours of symptoms. confirmedas of 2026-10-11
- Plague (fact sheet) · World Health Organization · Primary source (retrieved 2026-10-11)
- Plague (fact sheet) · World Health Organization · Primary source (retrieved 2026-10-11)
- [37]
Russian regulators told WHO there was no plague case, no evidence that pneumonic plague played a part in the death and that no pathogens had been detected. confirmedas of 2026-10-07
- 'No plague case' in Siberia, Russia tells WHO as assessments continue · UN News · Primary source · 2026-10-07 (retrieved 2026-10-11)
- [38]
On 8 October Russian authorities said monitoring of all the worker's contacts had concluded and that nearly 5,000 laboratory tests had found no dangerous pathogens. confirmedas of 2026-10-08
- Russia Says Checks Following Siberian Plague Lab Death Are Complete · The Moscow Times · Secondary source · 2026-10-08 (retrieved 2026-10-11)
- Russia says no epidemic risk as WHO pushes for transparency on plague lab death · CNN · Secondary source · 2026-10-07 (retrieved 2026-10-11)
- [39]
WHO defines antimicrobial resistance (AMR) as bacteria, viruses, fungi and parasites no longer responding to antimicrobial medicines, which makes infections difficult or impossible to treat. confirmedas of 2026-11-07
- Antimicrobial resistance (fact sheet) · World Health Organization · Primary source · 2026-07-16 · Key facts (retrieved 2026-11-07)
- [40]
The GRAM study in The Lancet (2024) estimated that bacterial AMR directly caused 1.14 million deaths in 2021 and was associated with 4.71 million deaths. confirmedas of 2024-09-16
- The Lancet: More than 39 million deaths from antibiotic-resistant infections estimated between now and 2050, suggests first global analysis · Institute for Health Metrics and Evaluation (GRAM study authors) · Primary source · 2024-09-16 (retrieved 2026-11-07)
- [41]
WHO says misuse and overuse of antibiotics, such as taking them when they are not needed or taking the wrong type, remains one of the main drivers of AMR. confirmedas of 2026-11-07
- Antimicrobial resistance (fact sheet) · World Health Organization · Primary source · 2026-07-16 · Antibiotic use (retrieved 2026-11-07)
- [42]
WHO's 2025 pipeline analysis found the number of antibacterials in clinical development fell from 97 in 2023 to 90 in 2025, of which 50 are traditional antibacterial agents and 40 are non-traditional approaches such as bacteriophages and antibodies. confirmedas of 2025-10-02
- WHO releases new reports on new tests and treatments in development for bacterial infections · World Health Organization · Primary source · 2025-10-02 (retrieved 2026-11-07)
- [43]
Of the 90 antibacterials in clinical development, WHO counts only 15 as innovative and only 5 as effective against at least one of its "critical" priority bacteria. confirmedas of 2025-10-02
- WHO releases new reports on new tests and treatments in development for bacterial infections · World Health Organization · Primary source · 2025-10-02 (retrieved 2026-11-07)
- WHO releases new reports on new tests and treatments in development for bacterial infections · World Health Organization · Primary source · 2025-10-02 (retrieved 2026-11-07)
- [44]
On 23 May 2026 member states at the 79th World Health Assembly adopted the updated Global Action Plan on Antimicrobial Resistance for 2026–2036, which builds on the original plan adopted in 2015. confirmedas of 2026-05-25
- The World Health Assembly adopts updated Global Action Plan on Antimicrobial Resistance (2026–2036) · World Health Organization · Primary source · 2026-05-25 (retrieved 2026-11-07)
- The World Health Assembly adopts updated Global Action Plan on Antimicrobial Resistance (2026–2036) · World Health Organization · Primary source · 2026-05-25 (retrieved 2026-11-07)
- [45]
The 5th Global High-Level Ministerial Conference on AMR, originally scheduled for 28–30 June 2026 in Abuja, Nigeria, was postponed and is now scheduled for 6–8 December 2026. confirmedas of 2026-11-07
- Abuja meeting postponed: a moment to close the gaps before ministers reconvene · ReAct (Action on Antibiotic Resistance) · Secondary source · 2026-06-26 (retrieved 2026-11-07)
- 5th Global High-Level Ministerial Conference on Antimicrobial Resistance (AMR) · Quadripartite Joint Secretariat on AMR · Primary source (retrieved 2026-11-07)
- [46]
WHO usually makes its vaccine composition recommendations in February for the next northern hemisphere season and in September for the next southern hemisphere season, timed to allow about 6-8 months for production, regulatory approval and distribution. confirmedas of 2026-02-27
- Questions and answers: recommended composition of influenza virus vaccines for the northern hemisphere 2026-2027 season · World Health Organization · Primary source · 2026-02-27 · Question 1 (retrieved 2026-11-07)
- Questions and answers: recommended composition of influenza virus vaccines for the northern hemisphere 2026-2027 season · World Health Organization · Primary source · 2026-02-27 · Question 1 (retrieved 2026-11-07)
- [47]
Licensed vaccines against meningococcal, pneumococcal and Haemophilus influenzae disease target the most harmful strains, and no universal meningitis vaccine exists. confirmedas of 2026-10-11
- Meningitis (fact sheet) · World Health Organization · Primary source (retrieved 2026-10-11)
Revision history (1)
- Page created.
Created Nov 7, 2026. Last reviewed by an editor on Nov 8, 2026. Next scheduled review: Dec 9, 2026.
Cite this page
"Infectious disease in 2026: a crash course." ContentLora, updated Nov 7, 2026. https://contentlora.com/explain/infectious-disease
Spotted an error? Suggest a correction or emailcorrections@contentlora.com.